Aug 24, 2016, 12:08 pm EDT
Germany is advising its citizens to stockpile food in case of an attack.
The news claims that Germany will enact a new civil defense strategy later today that will require citizens to keep 10 days worth of food in their households. The move will also make it so that Germans must keep five days worth of drinking water in their homes at all times.
Germany’s new civil defense strategy is part of a 69-page document that will be looked over by the Interior Ministry cabinet on Wednesday before being presented by the minister later in the day. This document reportedly claims that it is unlikely Germans will see an attack on their country. The new strategy was originally commissioned in 2012, reports Reuters. Read
Aug 23, 2016, 4:55 pm EDT
The New York Times Co (NYSE:NYT) is reportedly the victim of a cyberattack launched by Russian spies.
It is believed that hackers from the European nation tapped into the newspaper due to the fact that it is one of the preeminent sources of information, possibly containing sensitive information such as U.S. intelligence.
The move is also believed to be part of a broader effort that’s targeting organizations affiliated with the Democratic Party, as these hackers are looking to take down Hillary Clinton in the upcoming presidential election. Read
Aug 18, 2016, 12:25 pm EDT
In the last two years, gun stocks Sturm, Ruger & Company (NYSE: RGR) and Smith & Wesson Holding Corp (NASDAQ: SWHC) have both more than doubled the return of the S&P 500. Fears have never been higher concerning a potential Hillary Clinton presidency and the recent rise in high-profile mass shootings.
Source: Stephen Z via Flickr
Gun enthusiast are afraid that the current climate will ultimately lead to new, restrictive gun laws. Unfortunately for gun stocks like RGR and SWHC, November will likely bring bad news no matter who is elected.
RGR and SWHC Hot Streak
Incredibly, the FBI recently reported a record 2,197,169 background checks for gun sales in July. That number broke the previous July record by nearly 600,000. July marks the fifteenth consecutive month of record sales. Read
Aug 16, 2016, 10:28 am EDT
Aetna Inc (NYSE:AET) has announced plans to reduce the number of areas where it participates in Obamacare exchanges.
Aetna said that starting in 2017, it will no longer offer individual products through Obamacare exchanges in 536 counties across the United States. This means that it will be leaving 11 states. The company will continue to offer insurance in the majority of those areas, but it won’t be through Obamacare.
AET’s decision means that it will only be offering individual insurance through Obamacare exchanges in 242 counties in 2017. The states where Obamacare plans will still be offered are Delaware, Iowa, Nebraska and Virginia. Read
Aug 15, 2016, 4:59 pm EDT
The latest marijuana news sees Maryland making progress in the growing, distribution and sale of cannabis for medical purposes.
The Maryland Medical Cannabis Commission is expected to announce that it has approved 15 institutions to grow the plant and sell it to medical dispensaries. Each group of growers will receive a license, pending background checks.
More than 1,000 institutions applied to be considered for the growth of marijuana in the Old Line State. Additionally, the agency has chosen five alternates that could take over as growers if one or more of these institutions fail a background check. Read
Aug 11, 2016, 12:46 pm EDT
The Drug Enforcement Administration (DEA) has announced that marijuana will remain illegal under federal law.
The new report from the DEA has it denying two petitions to reschedule marijuana under the Controlled Substances Act (CSA). This means that the drug will continue to remain as a Schedule I controlled substance due to the requirements of the CSA.
The DEA noted that marijuana doesn’t meet the criteria for accepted medical use in treatment in the United States. This is due to a lack of safety around the drug and its “high potential for abuse” from users. The organization has ordered a scientific and medical evaluation and scheduling recommendation for the drug from the Department of Health and Human Services (HHS). Read